Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 6Crohn Disease 4Colitis, Ulcerative 4Colitis 4Carcinoma, Non-Small-Cell Lung 4Lung Neoplasms 3Inflammatory Bowel Diseases 3Arthritis, Rheumatoid 3Urogenital Neoplasms 2Inflammation 2Hematologic Neoplasms 2Graft vs Host Disease 2Fatigue 2Depressive Disorder, Major 2Depression 2Cachexia 2Anorexia 2Vasculitis 1Takayasu Arteritis 1Syndrome 1Stroke 1Stevens-Johnson Syndrome 1Skin Neoplasms 1Recurrence 1Rare Diseases 1Pemphigoid, Benign Mucous Membrane 1Pancreatic Neoplasms 1Lymphoma 1Kidney Transplantation 1Hypertension 1

Interventions

guselkumab 3tofacitinib 1sonelokimab 1risankizumab 1cabozantinib 1Vaccines 1Specimen Handling 1Saline Solution 1Platinum Compounds 1Nivolumab 1Ipilimumab 1Infliximab 1Herpes Zoster Vaccine 1Etanercept 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Arthritis, Psoriatic × Infliximab × Clear all
NCT00432406 2009-03-11

Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis

Chinese University of Hong Kong

Phase 4 Completed
40 enrolled

Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡